These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2427730)

  • 21. Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs.
    Preuss KC; Brooks HL; Gross GJ; Warltier DC
    Basic Res Cardiol; 1985; 80(3):326-32. PubMed ID: 2411255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The agonist effect of dihydropyridines on Ca channels.
    Brown AM; Kunze DL; Yatani A
    Nature; 1984 Oct 11-17; 311(5986):570-2. PubMed ID: 6207438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
    Takeda Y
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+-channel current and its modification by the dihydropyridine agonist BAY k 8644 in isolated smooth muscle cells.
    Droogmans G; Callewaert G
    Pflugers Arch; 1986 Mar; 406(3):259-65. PubMed ID: 2421242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gating and blocking of calcium channels by dihydropyridines in the pancreatic B-cell.
    Malaisse-Lagae F; Mathias PC; Malaisse WJ
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1062-8. PubMed ID: 6207819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropyridine sensitive calcium channels in a smooth muscle cell line.
    Kongsamut S; Freedman SB; Miller RJ
    Biochem Biophys Res Commun; 1985 Feb; 127(1):71-9. PubMed ID: 2579654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the actions of the calcium entry facilitator Bay K 8644 on the rat vas deferens.
    Hyland L; Warnock P; Docherty JR
    Eur J Pharmacol; 1984 Sep; 104(3-4):363-7. PubMed ID: 6209150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells.
    Kim D; Smith TW; Marsh JD
    J Clin Invest; 1987 Jul; 80(1):88-94. PubMed ID: 2439547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel types in cardiac myocytes: modulation by dihydropyridines and beta-adrenergic stimulation.
    Hess P; Lansman JB; Nilius B; Tsien RW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S11-21. PubMed ID: 2433538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Rogg H; Criscione L; Truog A; Meier M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-agonists.
    Bechem M; Schramm M
    J Mol Cell Cardiol; 1987 May; 19 Suppl 2():63-75. PubMed ID: 2442401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
    Franckowiak G; Bechem M; Schramm M; Thomas G
    Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
    Renaud JF; Méaux JP; Romey G; Schmid A; Lazdunski M
    Biochem Biophys Res Commun; 1984 Nov; 125(1):405-12. PubMed ID: 6210086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium channel activation in vascular smooth muscle by BAY K 8644.
    Su CM; Swamy VC; Triggle DJ
    Can J Physiol Pharmacol; 1984 Nov; 62(11):1401-10. PubMed ID: 6210137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine and BAY K inhibit contraction independently from their action on calcium channels.
    Jacquemond V; Rougier O
    Biochem Biophys Res Commun; 1988 May; 152(3):1002-7. PubMed ID: 2454099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.